iSTAR Medical Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 60

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $60M

iSTAR Medical General Information

Description

Developer of innovative ophthalmic implants designed to treat glaucoma. The company's implants exhibit anti-fibrotic and anti-inflammatory properties and are designed to enhance natural fluid outflow, reducing intraocular pressure and the need for medication, while bio-integrating with surrounding tissue, limiting inflammation, fibrosis, and subsequent complications, enabling glaucoma patients to get advanced, safe and effective treatment alternative for their disease.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Avenue Sabin, 6
  • 1300 Wavre
  • Belgium
+32 010
Primary Industry
Therapeutic Devices
Parent Company
Vertical(s)
Corporate Office
  • Avenue Sabin, 6
  • 1300 Wavre
  • Belgium
+32 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

iSTAR Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 30-Jun-2022 $60M Completed Generating Revenue
5. Debt - General 30-Jul-2021 Completed Generating Revenue
4. Later Stage VC (Series C) 05-Sep-2019 Completed Generating Revenue
3. Later Stage VC (Series B) 12-Apr-2016 Completed Generating Revenue
2. Early Stage VC (Series A) 14-Oct-2014 $5.09M $5.09M Completed Generating Revenue
1. Grant 14-Sep-2012 $4.54M Completed Generating Revenue
To view iSTAR Medical’s complete valuation and funding history, request access »

iSTAR Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Class C Preferred
Ordinary
Privilege 50,000 $236.49 $236.49 1x $236.49 16.51%
Privilege 40,000 $177.37 $177.37 1x $177.37 13.21%
To view iSTAR Medical’s complete cap table history, request access »

iSTAR Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of innovative ophthalmic implants designed to treat glaucoma. The company's implants exhibit anti-fibrotic and
Therapeutic Devices
Wavre, Belgium
60 As of 2025

Bedford, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

iSTAR Medical Competitors (1)

One of iSTAR Medical’s competitors is Ocular Therapeutix, a Formerly VC-backed company based in Bedford, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ocular Therapeutix Formerly VC-backed Bedford, MA
You’re viewing 1 of 1 competitors. Get the full list »

iSTAR Medical Patents

iSTAR Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023232241-A1 Delivery shaft assembly for delivery of an implant Pending 09-Mar-2022
EP-4489701-A1 Delivery shaft assembly for delivery of an implant Active 09-Mar-2022
EP-4489701-B1 Delivery shaft assembly for delivery of an implant Active 09-Mar-2022
EP-4489701-C0 Delivery shaft assembly for delivery of an implant Active 09-Mar-2022
ES-3057785-T3 Delivery shaft assembly for delivery of an implant Active 09-Mar-2022 A61F9/00781
To view iSTAR Medical’s complete patent history, request access »

iSTAR Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

iSTAR Medical Former Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
AWEX Corporation Minority
BNP Paribas Fortis Private Equity Growth/Expansion Minority
BioWin Other Minority
Capricorn Partners Venture Capital Minority
Demea Sustainable Investment PE/Buyout Minority
You’re viewing 5 of 17 investors. Get the full list »

iSTAR Medical Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Youco F21-H379 Vorrats Frankfurt A. Main, Germany 2021

iSTAR Medical FAQs

  • When was iSTAR Medical founded?

    iSTAR Medical was founded in 2010.

  • Where is iSTAR Medical headquartered?

    iSTAR Medical is headquartered in Wavre, Belgium.

  • What is the size of iSTAR Medical?

    iSTAR Medical has 60 total employees.

  • What industry is iSTAR Medical in?

    iSTAR Medical’s primary industry is Therapeutic Devices.

  • Is iSTAR Medical a private or public company?

    iSTAR Medical is a Private company.

  • What is the current valuation of iSTAR Medical?

    The current valuation of iSTAR Medical is .

  • What is iSTAR Medical’s current revenue?

    The current revenue for iSTAR Medical is .

  • How much funding has iSTAR Medical raised over time?

    iSTAR Medical has raised $84.5M.

  • Who are iSTAR Medical’s investors?

    AWEX, BNP Paribas Fortis Private Equity, BioWin, Capricorn Partners, and Demea Sustainable Investment are 5 of 17 investors who have invested in iSTAR Medical.

  • Who are iSTAR Medical’s competitors?

    Ocular Therapeutix is a competitor of iSTAR Medical.

  • When was iSTAR Medical acquired?

    iSTAR Medical was acquired on 30-Jun-2022.

  • Who acquired iSTAR Medical?

    iSTAR Medical was acquired by AbbVie.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process